Evidence map›Paper›PMID 42473545›Full record

ArticleAlzheimer's & dementia (New York, N. Y.)

Cerebrospinal fluid

Vincent Gabriel, Elena Chabran, Marion Sourty, Benjamin Cretin, Nathalie Philippi, Candice Muller, Pierre Anthony, Catherine Demuynck, Paulo Loureiro de Sousa, Anne Botzung and 3 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Alzheimer's & dementia (New York, N. Y.). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Vincent GabrielICube Laboratory UMR-7357 and FMTS (Fédération de Médecine Translationnelle de Strasbourg), IMIS team and IRIS platform University of Strasbourg and CNRS Strasbourg France.ORCID https://orcid.org/0009-0003-6107-4783
Elena ChabranICube Laboratory UMR-7357 and FMTS (Fédération de Médecine Translationnelle de Strasbourg), IMIS team and IRIS platform University of Strasbourg and CNRS Strasbourg France.
Marion SourtyICube Laboratory UMR-7357 and FMTS (Fédération de Médecine Translationnelle de Strasbourg), IMIS team and IRIS platform University of Strasbourg and CNRS Strasbourg France.
Benjamin CretinICube Laboratory UMR-7357 and FMTS (Fédération de Médecine Translationnelle de Strasbourg), IMIS team and IRIS platform University of Strasbourg and CNRS Strasbourg France.
Nathalie PhilippiICube Laboratory UMR-7357 and FMTS (Fédération de Médecine Translationnelle de Strasbourg), IMIS team and IRIS platform University of Strasbourg and CNRS Strasbourg France.
Candice MullerCM2R (Centre de Mémoire Ressources et Recherche), Geriatrics Department and Neurology Service Geriatric Day Hospital and Neuropsychological UnitUniversity Hospital of Strasbourg Strasbourg France.
Pierre AnthonyCM2R, Geriatrics Division Geriatric Day Hospital, Civil Hospitals of Colmar Colmar France.
Catherine DemuynckCM2R (Centre de Mémoire Ressources et Recherche), Geriatrics Department and Neurology Service Geriatric Day Hospital and Neuropsychological UnitUniversity Hospital of Strasbourg Strasbourg France.
Paulo Loureiro de SousaICube Laboratory UMR-7357 and FMTS (Fédération de Médecine Translationnelle de Strasbourg), IMIS team and IRIS platform University of Strasbourg and CNRS Strasbourg France.
Anne BotzungICube Laboratory UMR-7357 and FMTS (Fédération de Médecine Translationnelle de Strasbourg), IMIS team and IRIS platform University of Strasbourg and CNRS Strasbourg France.
Léa SannaCM2R (Centre de Mémoire Ressources et Recherche), Geriatrics Department and Neurology Service Geriatric Day Hospital and Neuropsychological UnitUniversity Hospital of Strasbourg Strasbourg France.
Olivier BousigesICube Laboratory UMR-7357 and FMTS (Fédération de Médecine Translationnelle de Strasbourg), IMIS team and IRIS platform University of Strasbourg and CNRS Strasbourg France.
Frédéric BlancICube Laboratory UMR-7357 and FMTS (Fédération de Médecine Translationnelle de Strasbourg), IMIS team and IRIS platform University of Strasbourg and CNRS Strasbourg France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionDementia with Lewy bodies (DLB) and Alzheimer's disease (AD) are neurocognitive disorders characterized by distinct but often overlapping pathological processes. These include

methodsSixty-nine DLB patients, 17 AD patients, and 24 patients with mixed AD/DLB underwent clinical and neuropsychological evaluations, lumbar puncture for CSF biomarker analysis (total

resultsIn DLB patients, lower CSF DISCUSSION: We identified distinct patterns of DMN and SN connectivity changes associated with CSF

Indexed as

alpha‐synucleinAlzheimer's diseaseamyloid beta 42cerebrospinal fluid biomarkersdefault mode networkdementia with lewy bodiesresting‐state fMRIRT‐QuICsalience networktau

Identifiers

PMID42473545
PMCPMC13380670

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.